SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREG FINLEY who wrote (448)1/28/2000 6:57:00 AM
From: geewiz  Read Replies (2) of 534
 
Hi Gerg,

Interesting observations on Medi-ject; that company had a narrow product line but very broad public relations. We have a broad product line but very narrow public relations. On a short flight up to the Twin Cities just before our reverse split I got seated next to a bio-med engineer from Medi-ject. I pumped him for any information on the company's plans. It was just before the VISION insulin injection system was introduced so he spoke at great length about that, but there was't anything elce even close to market. It did surprise me in December when Medi-ject released the DNA vaccine press release.... wonder how far that effort got past the PR.....the visit gave me some confidence over the markets' acceptance of MEDJ's reverse split - done about six months before our reverse split, and it gave me the confidence to get additional shares near last years' low, so although I gained from watching MEDJ I was never fooled about which company had the technology, and which had the tout!

later, art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News